Literature DB >> 12632089

Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.

Bin Chen1, Eric I Campos, Richard Crawford, Magdalena Martinka, Gang Li.   

Abstract

The incidence of basal cell carcinoma is the highest among all human malignancies. Epidemiological evidence indicates that ultraviolet radiation is the primary environmental cause for the pathogenesis of basal cell carcinoma. However, the genetic changes caused by ultraviolet radiation that lead to basal cell carcinoma formation remain unclear. We and others have demonstrated that the ING1 (inhibitor of growth 1) tumour suppressor plays an important role in cellular stress response to ultraviolet irradiation, such as DNA repair and apoptosis. This study was designed to investigate whether ING1 is overexpressed and/or mutated in human basal cell carcinoma. Immunohistochemistry, single-strand conformation polymorphism, and DNA sequencing were used to determine the expression and mutational status of the ING1 gene in 54 basal cell carcinoma biopsies. Immunohistochemical staining demonstrated that ING1 is overexpressed in 25% (6/24) human basal cell carcinomas. Single-strand conformation polymorphism and DNA sequencing revealed that only 1 in 54 (1.8%) basal cell carcinoma primaries contained a missense mutation in the ING1 gene. The mutation is located in exon 2 and could thus potentially interfere with the structure of every ING1 isoforms and the functions of the PHD zinc finger motif. Our data indicate that overexpression and mutation of the ING1 gene are infrequent in human basal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632089

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.

Authors:  Li-Sheng Chen; Jian-Bao Wei; Yong-Chun Zhou; Sen Zhang; Jun-Lin Liang; Yun-Fei Cao; Zong-Jiang Tang; Xiao-Long Zhang; Feng Gao
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 3.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

4.  Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.

Authors:  Frauke Goeman; Dorit Thormeyer; Maria Abad; Manuel Serrano; Oliver Schmidt; Ignacio Palmero; Aria Baniahmad
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma.

Authors:  Guan-Zhen Yu; Ming-Hua Zhu; Zhi Zhu; Can-Rong Ni; Jian-Ming Zheng; Fang-Mei Li
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 6.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 7.  PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Authors:  Lindsey A Baker; C David Allis; Gang G Wang
Journal:  Mutat Res       Date:  2008-07-17       Impact factor: 2.433

8.  Identification of differentially expressed cDNAs in Acanthamoeba culbertsoni after mouse brain passage.

Authors:  Kyu-Lee Han; Jongweon Lee; Don-Soo Kim; Soon-Jung Park; Kyung-il Im; Tai-Soon Yong
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

9.  mRNA and protein of p33ING1 in normal and cancer tissues.

Authors:  Shuang Zhao; Hua-Chuan Zheng
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.